Medtronic, Inc., a global leader in medical technology, is headquartered in the United States and operates extensively across North America, Europe, and Asia. Founded in 1949, the company has achieved significant milestones, including pioneering innovations in cardiac devices and diabetes management. Medtronic's core offerings encompass a wide range of products, such as insulin pumps, pacemakers, and surgical equipment, distinguished by their advanced technology and commitment to improving patient outcomes.
With a strong market position, Medtronic is recognised for its contributions to minimally invasive therapies and chronic disease management. The company’s dedication to research and development has solidified its reputation as a trusted provider in the healthcare industry, making it a vital player in enhancing the quality of life for patients worldwide.
+19 vs industry average
Medtronic, Inc.’s score of 42 is higher than 64% of the industry. This can give you a sense of how well the company is doing compared to its peers.
Part of the Sustainability team at Medtronic, Inc.?
- Control how your company's emission story is told
- Respond to customers efficiently
- See who's viewing your profile
Industry Intensity
Health Services has typical carbon intensity
Industry performance
The Health Services industry has reduced its overall emissions by 23% since 2018
Reported emissions
No reported emissions data is available for Medtronic, Inc. yet.
Medtronic, Inc.'s reported carbon emissions
Medtronic, Inc., headquartered in the US, currently does not have specific carbon emissions data available for the most recent year. The company is a current subsidiary of Medtronic plc, which influences its climate commitments and emissions reporting.
As part of its climate strategy, Medtronic plc has set various reduction initiatives, although specific targets or achievements for Medtronic, Inc. are not detailed. The emissions data and climate initiatives are cascaded from Medtronic plc, which is responsible for the overarching sustainability goals and reporting.
Medtronic plc is engaged in several industry-standard climate initiatives, including the Science Based Targets initiative (SBTi) and the Carbon Disclosure Project (CDP), which guide its emissions reduction strategies. However, specific reduction targets for Medtronic, Inc. have not been disclosed.
In summary, while Medtronic, Inc. inherits its climate commitments and emissions data from Medtronic plc, detailed emissions figures and specific reduction targets remain unspecified at this time.
Unlock detailed emission data
Access structured emission data, company specific factors and auditable source documents
Medtronic, Inc.’s Climate Goals (2030 & 2050)
No climate goals have been disclosed for Medtronic, Inc. yet.
Scope 3 top emissions categories
No scope 3 category breakdown has been disclosed yet.
Climate initiatives
Science Based Targets Initiative
Inherited from Medtronic plc
Carbon Disclosure Project
Inherited from Medtronic plc
The Climate Pledge
UN Global Compact Climate Champions initiative
RE 100
Climate Action 100
Emissions comparison with industry peers
View similar organisations
Medtronic, Inc.
Usage policy
You’re welcome to quote or reference data from this page, but please include a visible link back to this URL. Bulk collection, resale, or redistribution of data from multiple profiles is not permitted.
See our License Agreement for more details.
Where does DitchCarbondata come from?
Discover our data-driven methodology for measuring corporate climate action and benchmarking against industry peers
Learn moreCurious to see your top suppliers emissions?
Book a demo for a pilot project